Today, Kineon, a frontrunner in the biotech and health-tech industry, announced the launch of their Regulation Crowdfunding campaign on Start Engine. The company, renowned for its revolutionary at-home red light therapy device, the MOVE+ Pro, has achieved remarkable growth with over 9,000 units sold and a stunning $3.5 million in sales. Kineon's crowdfunding initiative is set to catalyze its mission of providing effective, non-pharmaceutical alternatives for pain management and treatment.
Kineon's crowdfunding campaign aims to bolster the rapid development and commercial expansion of its technology, which is redefining the landscape of light therapy. With impressive monthly revenue growth from $50K to $400K in less than 9 months, Kineon's technology has proven its strong market demand, previously raising $1.35M on Indiegogo and cultivating a supportive community of users.
"We couldn't be more thrilled about inviting the public to join us in our #MovePainFree movement," said Forrest Smith, co-founder and CEO of Kineon. "Our vision is to illuminate a new path to wellness, delivering world-class therapy at everyone's doorstep. The collective power of our investors will undeniably aid us in making significant strides in the medical field."
Kineon’s laser therapy devices have garnered glowing reviews and endorsements from world-class athletes and professional leagues. Kineon has also positioned themselves to tap into the chronic pain market, which experts project to reach $142.5B by 2033. With FDA and FCC clearance, Kineon is on the cusp of deploying a second core product and has more on the roadmap for the future.
Those who wish to be part of this transformative journey can learn more about the investment opportunity on Kineon's crowdfunding campaign on Start Engine.
For more information about this opportunity, visit www.startengine.com/offering/kineon.
Kineon is a pioneering force in the biotech and health-tech sector, focused on innovating medical treatment through advanced laser therapy technology. With a mission to provide effective non-pharmaceutical alternatives for pain management, Kineon's groundbreaking devices have made significant waves in the healthcare industry.
With over 9,000 units sold and endorsements from world-class athletes and professional leagues, Kineon is reshaping the perception of light therapy. The company's commitment to enhancing wellness and health is reflected in its rapidly expanding community of users and its proactive approach to future developments. For more information, visit Kineon's website.
Name: Tom Sanderson
Title at Company Name: COO and Co-founder
Social Media Links: https://www.instagram.com/kineon_labs/
Release ID: 398078